| __timestamp | Geron Corporation | TG Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 20707000 | 31354781 |
| Thursday, January 1, 2015 | 17831000 | 43445817 |
| Friday, January 1, 2016 | 18047000 | 66489820 |
| Sunday, January 1, 2017 | 11033000 | 96886134 |
| Monday, January 1, 2018 | 13432000 | 153793000 |
| Tuesday, January 1, 2019 | 52072000 | 148369000 |
| Wednesday, January 1, 2020 | 51488000 | 151934000 |
| Friday, January 1, 2021 | 85727000 | 198532000 |
| Saturday, January 1, 2022 | 95518000 | 112128000 |
| Sunday, January 1, 2023 | 125046000 | 76192000 |
Unleashing the power of data
In the competitive landscape of biotechnology, research and development (R&D) investments are crucial for innovation and growth. Over the past decade, TG Therapeutics, Inc. and Geron Corporation have demonstrated contrasting strategies in their R&D expenditures. From 2014 to 2023, TG Therapeutics consistently outpaced Geron, with its R&D spending peaking in 2021 at nearly double that of Geron. However, Geron has shown a remarkable upward trend, increasing its R&D investment by over 500% from 2014 to 2023. This surge highlights Geron's commitment to advancing its pipeline, particularly in the field of oncology. Meanwhile, TG Therapeutics' fluctuating investments reflect its strategic shifts and market responses. As these companies continue to innovate, their R&D strategies will play a pivotal role in shaping their future success and impact on the biotech industry.
Analyzing R&D Budgets: GSK plc vs TG Therapeutics, Inc.
Biogen Inc. vs Geron Corporation: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Ascendis Pharma A/S and TG Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Jazz Pharmaceuticals plc and Geron Corporation
Who Prioritizes Innovation? R&D Spending Compared for TG Therapeutics, Inc. and Viking Therapeutics, Inc.
Annual Revenue Comparison: TG Therapeutics, Inc. vs Geron Corporation
Comparing Innovation Spending: TG Therapeutics, Inc. and Dynavax Technologies Corporation
Research and Development Expenses Breakdown: Amneal Pharmaceuticals, Inc. vs Geron Corporation
Xenon Pharmaceuticals Inc. or Geron Corporation: Who Invests More in Innovation?
R&D Insights: How Supernus Pharmaceuticals, Inc. and Geron Corporation Allocate Funds
Research and Development Investment: Soleno Therapeutics, Inc. vs Geron Corporation
Comparing Innovation Spending: Geron Corporation and Viridian Therapeutics, Inc.